1. Enrollment Begins for Stentys’ Apposition II

    December 4, 2009—Stentys, Inc. (Princeton, NJ) announced the commencement of enrollment in the APPOSITION II clinical study, which is a randomized trial comparing the Stentys self-expanding stent with a conventional balloon-expandable stent in acute myocardial infarction (AMI) patients. The study’s primary endpoint is stent strut apposition at day 3 postprocedure via extremely high-resolution optical coherence tomography (OCT) imaging. Stefan Verheye, MD, PhD, is principal investigator of APPOSTION II, and Professor Christian Spaulding, MD, PhD, enrolled the study’s first patient at the Cochin Hospital, Descartes University in Paris.
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks